Strides Shasun has received 3 observations issued by the US health regulator after inspecting formulations facility in Bangalore.
Strides Shasun has said in a BSE filing that “The formulation facility in Bangalore was recently inspected by the USFDA. The company has been issued a Form 483 with 3 observations.”
It added that “None of these observations relate to data integrity and quality control. The company will address the observations comprehensively.”
